Matrix Laboratories Ltd is planning to raise funds up to USD 200 million by way of GDR/ADR/FCCB or shares on preferential basis or a combination thereof. The funds will be utilised for the repayment of its bridge loan and also to meet its future growth requirements.
Further, the management is considering employee stock option plan (ESOP) to the employees of subsidiary companies. The company has called an extraordinary general meeting of the members of the company on March 1, 2006, for obtaining the requisite approvals of the members: